These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33346512)

  • 1. An Observational Study of the Application of a Topical Cannabinoid Gel on Sensitive Dry Skin.
    Maghfour J; Rietcheck HR; Rundle CW; Runion TM; Jafri ZA; Dercon S; Lio P; Fernandez J; Fujita M; Dellavalle RP; Yardley H
    J Drugs Dermatol; 2020 Dec; 19(12):1204-1208. PubMed ID: 33346512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual Article: A Novel 3-Step Over-the-Counter Eczema Regimen Improves Eczema Severity, Itch, and Life Quality: Randomized Study.
    Hawley K; Lio P; Nguyen T; Qureshi A; Emesiani C; Meckfessel M
    J Drugs Dermatol; 2023 Oct; 22(10):SF388641s21-SF388641s26. PubMed ID: 37801543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes.
    Silverberg JI; Thyssen JP; Simpson EL; Yosipovitch G; Ständer S; Valdez H; Rojo R; Biswas P; Myers DE; Feeney C; DiBonaventura M
    Am J Clin Dermatol; 2021 Jul; 22(4):541-554. PubMed ID: 33954933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experiences from daily practice of upadacitinib treatment on atopic dermatitis with a focus on hand eczema: Results from the BioDay registry.
    Kamphuis E; Loman L; Han HL; Romeijn GLE; Politiek K; Schuttelaar MLA
    Contact Dermatitis; 2023 May; 88(5):351-362. PubMed ID: 36621910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis.
    Yosipovitch G; Reaney M; Mastey V; Eckert L; Abbé A; Nelson L; Clark M; Williams N; Chen Z; Ardeleanu M; Akinlade B; Graham NMH; Pirozzi G; Staudinger H; Plaum S; Radin A; Gadkari A
    Br J Dermatol; 2019 Oct; 181(4):761-769. PubMed ID: 30729499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically meaningful improvements in cutaneous lesions and quality of life measures in patients with atopic dermatitis with greater pruritus reductions after treatment with 60 mg nemolizumab subcutaneously every 4 weeks: subgroup analysis from a phase 3, randomized, controlled trial.
    Kabashima K; Matsumura T; Hayakawa Y; Kawashima M;
    J Dermatolog Treat; 2023 Dec; 34(1):2177096. PubMed ID: 36779675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Relevance of Skin Pain in Atopic Dermatitis.
    Ständer S; Simpson EL; Guttman-Yassky E; Thyssen JP; Kabashima K; Ball SG; Rueda MJ; DeLozier AM; Silverberg JI
    J Drugs Dermatol; 2020 Oct; 19(10):921-926. PubMed ID: 33026764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual Article: Efficacy of Over-The-Counter Cream in Reducing Eczema Signs.
    Hebert AA; Grivet-Seyve M; Anjuwon S; Piccardi N; Lachmann N; Cruz A; Emesiani C
    J Drugs Dermatol; 2023 Oct; 22(10):SF388641s5-SF388641s9. PubMed ID: 37801541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and confocal evaluation of avenanthramides-based daily cleansing and emollient cream in pediatric population affected by atopic dermatitis and xerosis.
    Diluvio L; Dattola A; Cannizzaro MV; Franceschini C; Bianchi L
    G Ital Dermatol Venereol; 2019 Feb; 154(1):32-36. PubMed ID: 30207438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of five patient-reported outcomes for atopic dermatitis severity in adults.
    Silverberg JI; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Ong PY; Fuxench ZC; Simpson EL
    Br J Dermatol; 2020 Jan; 182(1):104-111. PubMed ID: 30972740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Hand Eczema in Adults.
    Barrett A; Hahn-Pedersen J; Kragh N; Evans E; Gnanasakthy A
    Patient; 2019 Oct; 12(5):445-459. PubMed ID: 31270775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase 1 studies to assess the safety, tolerability and pharmacokinetics of JTE-052 (a novel Janus kinase inhibitor) ointment in Japanese healthy volunteers and patients with atopic dermatitis.
    Nakagawa H; Nemoto O; Yamada H; Nagata T; Ninomiya N
    J Dermatol; 2018 Jun; 45(6):701-709. PubMed ID: 29665062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Pruritic Efficacy of Itch Relief Lotion and Cream in Patients With Atopic History: Comparison With Hydrocortisone Cream.
    Zirwas MJ; Barkovic S
    J Drugs Dermatol; 2017 Mar; 16(3):243-247. PubMed ID: 28301620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement properties of the Patient-Reported Outcomes Information System (PROMIS
    Silverberg JI; Lai JS; Patel KR; Singam V; Vakharia PP; Chopra R; Sacotte R; Kantor R; Hsu DY; Cella D
    Br J Dermatol; 2020 Nov; 183(5):891-898. PubMed ID: 32107772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial.
    Mehrbani M; Choopani R; Fekri A; Mehrabani M; Mosaddegh M; Mehrabani M
    J Ethnopharmacol; 2015 Aug; 172():325-32. PubMed ID: 26151244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring atopic eczema symptoms in clinical practice: The first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiative.
    Leshem YA; Chalmers JR; Apfelbacher C; Furue M; Gerbens LAA; Prinsen CAC; Schmitt J; Spuls PI; Thomas KS; Williams HC; Simpson EL;
    J Am Acad Dermatol; 2020 May; 82(5):1181-1186. PubMed ID: 31926221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel topical agent containing superoxide dismutase 100 000 IU and 4% of plant extracts as a mono-therapy for atopic dermatitis.
    Sgouros D; Katoulis A; Rigopoulos D
    J Cosmet Dermatol; 2018 Dec; 17(6):1069-1072. PubMed ID: 29134748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Desoximetasone 0.25% Spray in Adult Atopic Dermatitis Subjects: Pilot Study.
    Hoffman LK; Kircik L
    J Drugs Dermatol; 2017 Sep; 16(9):919-922. PubMed ID: 28915287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-Reported Disease Burden and Unmet Therapeutic Needs in Atopic Dermatitis.
    Bacci E; Rentz A; Correll J; Pierce E; DeLozier A; Rueda M; Begolka W; Butler L
    J Drugs Dermatol; 2021 Nov; 20(11):1222-1230. PubMed ID: 34784136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Pruritus in Relation to Self-assessed Severity of Atopic Dermatitis.
    Huet F; Faffa MS; Poizeau F; Merhand S; Misery L; Brenaut E
    Acta Derm Venereol; 2019 Mar; 99(3):279-283. PubMed ID: 30264161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.